Management of central serous chorioretinopathy: Expert panel discussion

被引：5

作者：

Chhablani, Jay ^{[1
]}

Anantharaman, Giridhar ^{[2
]}

Behar-Cohen, Francine ^{[3
,4
,5
,6
]}

Boon, Camiel ^{[7
,8
]}

Manayath, George ^{[9
]}

Singh, Rishi ^{[10
]}

机构：

[1] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreoretinal Dis, Banjara Hills, Hyderabad 500034, Telangana, India

[2] Giridhar Eye Inst, Dept Vitreoretinal Serv, Cochin, Kerala, India

[3] Univ Lausanne, Dept Ophthalmol, Jules Gonin Eye Hosp, Fdn Asile des Aveugles, Lausanne, Switzerland

[4] UPMC Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, Team 1 & 17, Paris, France

[5] Ctr Rech Cordeliers, INSERM, Paris, France

[6] Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Cordeliers, Paris, France

[7] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands

[8] Univ Amsterdam, Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands

[9] Aravind Eye Hosp, Dept Retina & Ocular Oncol, Coimbatore, Tamil Nadu, India

[10] Cole Eye Inst, Cleveland, OH USA

来源：

INDIAN JOURNAL OF OPHTHALMOLOGY | 2018年 / 66卷 / 12期

关键词：

Central serous chorioretinopathy; management; choroid; retina; expert panel;

D O I：

10.4103/ijo.IJO_1411_18

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Central serous chorioretinopathy (CSCR), one of the most common diseases in retina clinics, needs a special attention by retina specialists. Considering the challenges in diagnosis, classification, and management of this enigmatic disease and lack of level 1 evidence, there is a need for consensus with regard to establishing management protocols.

引用

页码：1700 / 1703

页数：4

共 50 条

[31] Central serous chorioretinopathy and glucocorticoids
Bouzas, EA
Karadimas, P
Pournaras, CJ
SURVEY OF OPHTHALMOLOGY, 2002, 47 (05) : 431 - 448
[32] Intravitreal Ranibizumab for Acute Central Serous Chorioretinopathy
Lee, Seung Jun
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[33] Choroidal vessel diameter in central serous chorioretinopathy
Yang, Lihong
Jonas, Jost B.
Wei, Wenbin
ACTA OPHTHALMOLOGICA, 2013, 91 (05) : E358 - E362
[34] ACUTE CENTRAL SEROUS CHORIORETINOPATHY Factors Influencing Episode Duration
Daruich, Alejandra
Matet, Alexandre
Marchionno, Laetitia
De Azevedo, Jean-Dominique
Ambresin, Aude
Mantel, Irmela
Behar-Cohen, Francine
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2017, 37 (10): : 1905 - 1915
[35] Brachytherapy for Central Serous Chorioretinopathy
Arora, Supriya
Stea, Baldassarre D.
Hamilton, Russell J.
Chhablani, Jay
OPHTHALMOLOGY AND THERAPY, 2022, 11 (05) : 1611 - 1616
[36] Central serous chorioretinopathy: A review
Fung, Adrian T. T.
Yang, Yi
Kam, Andrew W. W.
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (03) : 243 - 270
[37] Biomarkers for central serous chorioretinopathy
Nkrumah, Gideon
Paez-Escamilla, Manuel
Singh, Sumit Randhir
Rasheed, Mohammed Abdul
Maltsev, Dmitri
Guduru, Abhilash
Chhablani, Jay
THERAPEUTIC ADVANCES IN OPHTHALMOLOGY, 2020, 12
[38] Occult Central Serous Chorioretinopathy
Freund, K. Bailey
Warrow, David
Gallego-Pinazo, Roberto
Quan Hoang
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[39] CENTRAL SEROUS CHORIORETINOPATHY IN WOMEN
Musetti, Donatella
Nicolo, Massimo
Traverso, Carlo
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[40] Central serous chorioretinopathy and stress
Conrad, R
Bodeewes, I
Schilling, G
Geiser, F
Imbierowicz, K
Liedtke, R
OPHTHALMOLOGE, 2000, 97 (08): : 527 - 531

← 1 2 3 4 5 →